58-17b-907. Rules made by the division.

383 words·~2 min read·/ut/title-58/chapter-17b/58-17b-907

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Effective 7/1/2022

The rules made by the division under Subsection 58-17b-903(2)(b) shall include:

(1)registration requirements to establish the eligibility of a pharmacy to participate in the program;

(2)a formulary that includes all eligible prescription drugs approved by the federal Food and Drug Administration;

(3)standards and procedures for:

(a)verifying whether a pharmacy or pharmacist participating in the program is licensed and in good standing with the board;

(b)handling of an eligible prescription drug transferred in accordance with Subsection 58-17b-903(2) to an eligible pharmacy or a physician's office, including:

(i)acceptance;

(ii)identification, including redundant criteria for verification;

(iii)documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history, and statements;

(iv)safe storage;

(v)security;

(vi)inspection;

(vii)transfer; and

(viii)dispensing;

(c)a pharmacist, pharmacy intern, or licensed pharmacy technician:

(i)working in or consulting with a participating eligible donor; or

(ii)assisting an individual donating the eligible prescription drug;

(d)disposition of a donated prescription drug that is a controlled substance;

(e)record keeping regarding:

(i)the individual or eligible donor that transferred an eligible prescription drug under Subsection 58-17b-903(2)(a) ;

(ii)the identification and evaluation of a donated prescription drug by a pharmacist or licensed pharmacy technician; and

(iii)the dispensing or disposition of a prescription drug;

(f)determining the status of a medically indigent individual;

(g)labeling requirements to:

(i)ensure compliance with patient privacy laws relating to:

(A)an individual who receives an eligible prescription drug; and

(B)patient information that may appear on a donated prescription drug;

(ii)clearly identify an eligible prescription drug dispensed under the program; and

(iii)communicate necessary information regarding the manufacturer's recommended expiration date or the beyond use date; and

(h)ensuring compliance with the requirements of this part;

(4)a process for seeking input from the Department of Health and Human Services created in Section 26B-1-201 to:

(a)establish program standards and procedures for assisted living facilities and nursing care facilities; and

(b)establish program standards and procedures for mental health and substance abuse clients; and

(5)the creation of a special training program that a pharmacist and a licensed pharmacy technician at an eligible pharmacy must complete before participating in the program.

Amended by Chapter 255 , 2022 General Session